Piper Sandler Initiates Coverage On Zura Bio with Overweight Rating, Announces Price Target of $26
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Yasmeen Rahimi initiates coverage on Zura Bio (NASDAQ:ZURA) with an Overweight rating and a price target of $26.
May 03, 2024 | 9:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler initiated coverage on Zura Bio with an Overweight rating and set a price target of $26.
The initiation of coverage by Piper Sandler with an Overweight rating and a price target significantly above the current trading price is likely to be viewed positively by the market. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100